PL434617A1 - 7-O-hexylnaringenin oxime and method of its preparation - Google Patents

7-O-hexylnaringenin oxime and method of its preparation

Info

Publication number
PL434617A1
PL434617A1 PL434617A PL43461720A PL434617A1 PL 434617 A1 PL434617 A1 PL 434617A1 PL 434617 A PL434617 A PL 434617A PL 43461720 A PL43461720 A PL 43461720A PL 434617 A1 PL434617 A1 PL 434617A1
Authority
PL
Poland
Prior art keywords
hexylnaringenin
oxime
preparation
formula
application
Prior art date
Application number
PL434617A
Other languages
Polish (pl)
Other versions
PL240961B1 (en
Inventor
Joanna Kozłowska
Original Assignee
Uniwersytet Przyrodniczy we Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Przyrodniczy we Wrocławiu filed Critical Uniwersytet Przyrodniczy we Wrocławiu
Priority to PL434617A priority Critical patent/PL240961B1/en
Publication of PL434617A1 publication Critical patent/PL434617A1/en
Publication of PL240961B1 publication Critical patent/PL240961B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Przedmiotem zgłoszenia jest związek o nazwie: Oksym 7-O-heksylonaringeniny o wzorze 2 przedstawiony na rysunku. Zgłoszenie obejmuje także sposób otrzymywania oksymu 7-O-heksylonaringeniny polegający na tym, że do substratu, którym jest 7-O-heksylonaringenina o wzorze 1 dodaje się chlorowodorek hydroksyloaminy oraz bezwodny octan sodu w stosunku molowym co najmniej 1:1,5:1,5 oraz minimalną ilość alkoholu, co stanowi mieszaninę reakcyjną, którą pozostawia się w temperaturze od 30°C do 55°C na okres od 1 do 24 godzin przy ciągłym mieszaniu, po czym mieszaninę wylewa się do wody z lodem, wytrącony osad sączy się pod zmniejszonym ciśnieniem, a następnie otrzymany surowy produkt oczyszcza się.The subject of the application is the compound named: 7-O-hexylnaringenin oxime of formula 2 shown in the figure. The application also covers a method for the preparation of 7-O-hexylnaringenin oxime, which consists in adding hydroxylamine hydrochloride and anhydrous sodium acetate in a molar ratio of at least 1: 1.5: 1 to the substrate, which is 7-O-hexylnaringenin, of the formula 1, 5 and the minimum amount of alcohol, which is the reaction mixture, which is left at a temperature of 30 ° C to 55 ° C for 1 to 24 hours with continuous stirring, then the mixture is poured into ice water, the precipitate is filtered under reduced pressure, then the obtained crude product was purified.

PL434617A 2020-07-10 2020-07-10 7-O-hexylnaringenin oxime and method of its preparation PL240961B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL434617A PL240961B1 (en) 2020-07-10 2020-07-10 7-O-hexylnaringenin oxime and method of its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL434617A PL240961B1 (en) 2020-07-10 2020-07-10 7-O-hexylnaringenin oxime and method of its preparation

Publications (2)

Publication Number Publication Date
PL434617A1 true PL434617A1 (en) 2022-01-17
PL240961B1 PL240961B1 (en) 2022-07-04

Family

ID=80111424

Family Applications (1)

Application Number Title Priority Date Filing Date
PL434617A PL240961B1 (en) 2020-07-10 2020-07-10 7-O-hexylnaringenin oxime and method of its preparation

Country Status (1)

Country Link
PL (1) PL240961B1 (en)

Also Published As

Publication number Publication date
PL240961B1 (en) 2022-07-04

Similar Documents

Publication Publication Date Title
CA3061708C (en) Method for preparing intermediate of 4-methoxypyrrole derivative
MX2011012443A (en) Method for producing microcapsule.
PL434617A1 (en) 7-O-hexylnaringenin oxime and method of its preparation
PL434616A1 (en) 7,4'-di-O-hexylnaringenin oxime and method of its preparation
PL422961A1 (en) 7,4'-dipropoxy-naringenin oxime and method for obtaining 7,4'-dipropoxy-naringenin oxime
PL422927A1 (en) 5,7,4'-tripropoxy-naringenin oxime and method for obtaining 5,7,4'-tripropoxy naringenin oxime
PL421034A1 (en) 7,4'-diethoxy-naringenin-oxime and method for obtaining 7,4'-diethoxy-naringenin-oxime
PL422933A1 (en) 7,4'-dibutoxy-naringenin oxime and method for obtaining 7,4'-dibutoxy-naringenin oxime
PL422926A1 (en) 7-propoxy-naringenin oxime and method for obtaining 7-propoxy-naringenin oxime
PL422932A1 (en) 7-isopropoxy-naringenin oxime and method for obtaining 7-isopropoxy-naringenin oxime
PL421033A1 (en) 7-pentoxy-naringenin-oxime and method for obtaining 7-petoxy-naringenin-oxime
PL422935A1 (en) 7,4'-didecanoxy-naringenin oxime and method for obtaining 7,4'-didecanoxy-naringenin oxime
PL422936A1 (en) 7,4'-diisopropoxy-naringenin oxime and method for obtaining 7,4'-diisopropoxy-naringenin oxime
PL421031A1 (en) 7-ethoxy-naringenin-oxime and method for obtaining 7-ethoxy-naringenin-oxime
PL421041A1 (en) 7,4'-dipentoxy-naringenin-oxime and method for obtaining 7,4'-dipentoxy-naringenin-oxime
PL421043A1 (en) 7,4'-dimethoxy-naringenin-oxime and method for obtaining 7,4'-dimethoxy-naringenin-oxime
PL422930A1 (en) 7-butoxy-naringenin-oxime and method for obtaining 7-butoxy-naringenin-oxime
JPS61502959A (en) 4↓-(isoxazolyl)↓-thiazole↓-2↓-oxamic acid derivative
PL422931A1 (en) 7-decanoxy-naringenin-oxime and method for obtaining 7-decanoxy-naringenin-oxime
CA2673219C (en) O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists
PT96536A (en) PROCESS FOR PREPARING FUNGICIDE COMPOSITION CONTAINING SUBSTITUTED 2- {6- (PYRIMIDINYL) -INDOL-1-YL} -ACRYLATED ACID ESTERS AND INTERMEDIATE PRODUCTS
PL421042A1 (en) 5,7,4'-triethoxy-naringenin-oxime and method for obtaining 5,7,4'-triethoxy naringenin-oxime
PL427870A1 (en) 3-arylchromen-2-one derivative and method of producing 3-arylchromen-2-one derivative
CN116283832A (en) Preparation method of oseltamium Wei Gongyi impurity
IE47627B1 (en) Oxaminic acids and esters, process for their preparation and pharmaceutical compositions containing them